Artis Ventures — 2023 Investments
5 investments dated 2023 · listed companies and verified rows first · show all
Affect Therapeutics operates an app-based digital treatment provider offering care for substance use disorders (alcohol, cannabis, opioid) and mental health conditions like depression and anxiety, using methods such as contingency management, CBT, medication-assisted treatment, and peer support.
Digital HealthHealthtechMental HealthNew York, US
Jeff DeFlavio(Co-founder)inKristin Muhlner(Executive Officer, Director)in
BoardKevin Ryan(Director)Jeff Rinehart(Director)in
Co-investorsCity LightAlleyCorpLifeArc VenturesSamsung NextWhat If VenturesAllumia Ventures
Overt Bio develops cell therapies that link genes to immune functions using genome-scale discovery platforms.
AI & Machine LearningBiotechMedical DevicesNew York, US
Dr. Legut(Co-Founder and CEO)Dr. Sanjana(Co-Founder)Mateusz Legut(Executive Officer, Director)Neville Sanjana(Director)Mat Legut(Founder)in
Board seatVasudev Bailey· per SEC Form D
Co-investorsCivilization Ventures Management, LlcFusionHAWKTAILWingAlexandriaGaingels+1 more
Inceptive builds foundation models of biological systems for drug discovery, specializing in sequence-based medicines like mRNA and peptides.
AI & Machine LearningBiotechMedical DevicesPalo Alto, US
Jakob Uszkoreit(Executive Officer, Director, Promoter)Kevin Heyries(Executive Officer)Diana Isabel Ajuria(Executive Officer)Do Soon Kim(Executive Officer)
BoardVijay S. Pande(Director)in
Co-investorsAndreessen HorowitzObvious VenturesS32Section 32NVentures
Mytos develops automated manufacturing technology for regenerative medicines, specifically targeting the production of stem cell-derived therapies to make treatments for conditions like Parkinson's, blindness, and spinal cord injury accessible and affordable to patients.
Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical DevicesRoboticsLondon, GB
Ali Afshar(Founder/CEO)inIgnacio Willats(Founder)in
Co-investorsY CombinatorAcequia Capital (AceCap)Deep Science VenturesEmles Venture PartnersIQ CapitalKinled Holding+4 more
Range Bio (Range Biotechnologies) develops next-generation diagnostics using translational proteomics for applications in human health.
BiotechHealthtechMedical Devices
Brandon Wilson, Ph.D.(Co-founder & CEO)Brandon Wilson(Co-founder & CEO)
Co-investorsCivilization Ventures Management, LlcFifty YearsHAWKTAILPage One VenturesPear VCPillar
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.